Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains an error page, with the footer revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:55:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:06:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content. This prevents users from accessing the trial details and related information on that page.
    Difference
    21%
    Check dated 2026-09-20T20:26:18.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the page. This appears to be a backend version update with no changes to the study details or user-visible content.
    Difference
    0.1%
    Check dated 2026-08-30T21:54:13.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    No additions or deletions were listed for this page, so the content remains as published. The provided data shows no textual changes to assess in context.
    Difference
    0.0%
    Check dated 2026-08-23T18:53:18.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a minor version update to the page. This reflects internal maintenance rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-09T09:17:07.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.